Birth Defects Research Part B: Developmental and Reproductive Toxicology

Cover image for Vol. 107 Issue 3

Edited By: George P. Daston

Impact Factor: 0.768

ISI Journal Citation Reports © Ranking: 2014: 82/87 (Toxicology); 154/167 (Genetics & Heredity); 198/211 (Oncology)

Online ISSN: 1542-9741

Associated Title(s): Birth Defects Research Part A: Clinical and Molecular Teratology, Birth Defects Research Part C: Embryo Today: Reviews, Teratogenesis, Carcinogenesis, and Mutagenesis


Birth Defects Research is an official publication of the Teratology Society. Society members receive an electronic subscription to all three parts of Birth Defects Research as part of their membership dues. Society members may pay an additional fee to receive the journal in printed form. For more information about the Society and how to become a member, please visit

Aims and Scope

The purpose of this journal is to publish original contributions describing the toxicity of chemicals to developing organisms and the process of reproduction. The scope of the journal will inlcude:

• toxicity of new chemical entities and biotechnology derived products to developing organismal systems;
• toxicity of these and other xenobiotic agents to reproductive function;
• multi-generation studies;
• endocrine-mediated toxicity, particularly for endpoints that are relevant to development and reproduction;
• novel protocols for evaluating developmental and reproductive toxicity;
• approaches to the application of risk assessment for developmental and reproductive toxicants;
• toxicity related to direct exposure in juvenile animals.

Studies with in vivo and in vitro model systems will be the primary focus of the journal. Studies conducted to comply with regulations for the registration of pharmaceuticals, agro chemicals, chemicals or biotechnology derived products and provide data for safety/risk assessments are welcome, including testing to fulfill requirements for high-production volume, assessment of children’s health, endocrine disruptor screening and testing, and other governmentally mandated programs. Inclusion of comprehensive data that are necessary for complete interpretation of study results is encouraged, and tables and figures that are too extensive to publish in hard copy may be made available through an associated website. Manuscripts will be judged based on the appropriateness of the experiments, quality of the data, the presence of multiple dose levels, adequate statistical power, and the presence of information that allows estimation of the potential risk to human reproduction or development. The outcome of a study (i.e., whether an agent is a reproductive hazard) will not be used as criterion for acceptance of a manuscript.

Birth Defects Research consists of three parts:


Specialists in embryology, teratology, and prenatal development.


toxicology, reproduction, birth defects, pregnancy, safety assessment, embryology, teratology, epidemiology, developmental biology

Abstracting and Indexing Information

  • Abstracts in Anthropology (Baywood Publishing)
  • BIOBASE: Current Awareness in Biological Sciences (Elsevier)
  • Biological Abstracts (Thomson Reuters)
  • BIOSIS Previews (Thomson Reuters)
  • CAS: Chemical Abstracts Service (ACS)
  • Chemical Abstracts Service/SciFinder (ACS)
  • Chimica Database (Elsevier)
  • CrossFire Beilstein (Elsevier)
  • CSA Biological Sciences Database (ProQuest)
  • CSA Environmental Sciences & Pollution Management Database (ProQuest)
  • Current Contents: Life Sciences (Thomson Reuters)
  • HEED: Health Economic Evaluations Database (Wiley-Blackwell)
  • Journal Citation Reports/Science Edition (Thomson Reuters)
  • MEDLINE/PubMed (NLM)
  • Neurosciences Abstracts (ProQuest)
  • PASCAL Database (INIST/CNRS)
  • PubMed Dietary Supplement Subset (NLM)
  • Science Citation Index (Thomson Reuters)
  • SCOPUS (Elsevier)
  • Web of Science (Thomson Reuters)